| Literature DB >> 31360702 |
Guo-Zhe Sun1, Ying Zhou1, Ning Ye1, Shao-Jun Wu1, Ying-Xian Sun1.
Abstract
AIMS: We performed the current study primarily to characterize the independent association of blood pressure with heart rate-corrected QT (QTc) interval after adjusting for cardiovascular confounding factors and left ventricular mass (LVM) in a large general population in China.Entities:
Mesh:
Year: 2019 PMID: 31360702 PMCID: PMC6644263 DOI: 10.1155/2019/1656123
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Characteristics of the study population.
| Variable | Normal QTc | Prolonged QTc |
|
|---|---|---|---|
| ( | ( | ||
| Age, years | 53.2 ± 10.3 | 56.8 ± 10.8 | < 0.001 |
| Male | 4,239 (46.2) | 536 (39.1) | < 0.001 |
| Race of Han | 8,708 (94.8) | 1,303 (95.0) | 0.751 |
| BMI, kg/m2 | 24.7 ± 3.6 | 25.3 ± 3.9 | < 0.001 |
| SBP, mmHg | 139.9 ± 22.5 | 152.6 ± 25.5 | < 0.001 |
| DBP, mmHg | 81.3 ± 11.3 | 86.5 ± 13.0 | < 0.001 |
| Hypertension | 4,359 (47.5) | 982 (71.6) | < 0.001 |
| FBG, mmol/L | 5.84 ± 1.50 | 6.31 ± 2.27 | < 0.001 |
| TC, mmol/L | 5.21 ± 1.07 | 5.40 ± 1.16 | < 0.001 |
| TG, mmol/L | 1.59 ± 1.39 | 1.97 ± 1.96 | < 0.001 |
| LDL-C, mmol/L | 2.90 ± 0.81 | 3.05 ± 0.85 | < 0.001 |
| HDL-C, mmol/L | 1.41 ± 0.38 | 1.40 ± 0.40 | 0.441 |
| SUA, mg/dL | 4.87 ± 1.40 | 4.99 ± 1.53 | 0.007 |
| Calcium, mmol/L | 2.32 ± 0.13 | 2.34 ± 0.12 | < 0.001 |
| Potassium, mmol/L | 4.21 ± 0.34 | 4.09 ± 0.38 | < 0.001 |
| Magnesium, mmol/L | 0.85 ± 0.11 | 0.85 ± 0.08 | 0.117 |
| Current smoker | 3,243 (35.3) | 474 (34.6) | 0.590 |
| Current drinker | 2,073 (22.6) | 264 (19.3) | 0.006 |
| LVIDd, cm | 4.70 ± 0.41 | 4.74 ± 0.45 | 0.001 |
| IVS, cm | 0.87 ± 0.12 | 0.91 ± 0.14 | < 0.001 |
| PWT, cm | 0.85 ± 0.10 | 0.88 ± 0.12 | < 0.001 |
| LVMI, g/m2 | 81.1 ± 18.0 | 86.5 ± 21.7 | < 0.001 |
| LVH | 837 (9.1) | 251 (18.3) | < 0.001 |
| Heart rate, bpm | 70.3 ± 11.6 | 79.9 ± 13.1 | < 0.001 |
| QTc interval, ms | 423.3 ± 19.2 | 469.5 ± 18.9 | < 0.001 |
| History of heart disease† | 830 (9.0) | 210 (15.3) | < 0.001 |
| Medication used‡ | 4,745 (51.7) | 870 (63.5) | < 0.001 |
Abbreviations. BMI: body mass index; DBP: diastolic blood pressure; FBG: fasting blood glucose; HDL-C: high density lipid cholesterol; IVS: interventricular septum; LDL-C: low density lipid cholesterol; LVH: left ventricular hypertrophy; LVIDd: left ventricular internal diameter at end-diastole; LVMI: left ventricular mass index; PWT: posterior wall thickness; QTc: QT interval corrected for heart rate with Bazett's formula; SBP: systolic blood pressure; TC: total cholesterol; TG: triglycerides.
Note. Data are presented as mean ± standard deviation or n (%).
†Including coronary heart disease, arrhythmia, and heart failure.
‡Indicating any self-reported medication used in the past 2 weeks.
Figure 1Gender-specific mean heart rate-corrected QT (QTc) interval and prevalence of prolonged QTc interval stratified by hypertension and left ventricular hypertrophy (LVH).
Multivariate linear regression for association between blood pressure and QTc interval (ms).
| Group | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| Total | ||||||
| SBP, mmHg | 0.23 (0.21–0.25) | < 0.001 | 0.14 (0.12–0.16) | < 0.001 | 0.12 (0.10–0.14) | < 0.001 |
| DBP, mmHg | 0.46 (0.42–0.50) | < 0.001 | 0.20 (0.16–0.24) | < 0.001 | 0.16 (0.12–0.20) | < 0.001 |
| Male | ||||||
| SBP, mmHg | 0.28 (0.25–0.31) | < 0.001 | 0.19 (0.16–0.21) | < 0.001 | 0.16 (0.13–0.19) | < 0.001 |
| DBP, mmHg | 0.56 (0.51–0.62) | < 0.001 | 0.25 (0.20–0.30) | < 0.001 | 0.20 (0.14–0.25) | < 0.001 |
| Female | ||||||
| SBP, mmHg | 0.19 (0.16–0.22) | < 0.001 | 0.11 (0.09–0.14) | < 0.001 | 0.09 (0.07–0.12) | < 0.001 |
| DBP, mmHg | 0.37 (0.32–0.42) | < 0.001 | 0.15 (0.10–0.20) | < 0.001 | 0.12 (0.07–0.17) | < 0.001 |
Abbreviations as in Table 1.
Note. Model 1: adjusted for age, gender, race, SBP, and DBP; Model 2: additional adjustments for BMI, FBG, TC, TG, LDL-C, HDL-C, SUA, current smoking, drinking status, serum calcium, potassium and magnesium, heart rate, history of heart disease, and any medication used; Model 3: additional adjustments for LVMI.
Logistic regression analyses for association between hypertension and prolonged QTc interval.
| Group | Prolonged QTc | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|---|
|
| OR (95% CI) |
| OR (95% CI) |
| OR (95% CI) |
| |
| Total | |||||||
| Normotension | 389 (7.5) | 1 | 1 | 1 | |||
| Hypertension | 982 (18.4) | 2.48 (2.17–2.82) | < 0.001 | 1.79 (1.55–2.07) | < 0.001 | 1.71 (1.48–1.98) | < 0.001 |
| Male | |||||||
| Normotension | 120 (5.4) | 1 | 1 | 1 | |||
| Hypertension | 416 (16.3) | 2.99 (2.40–3.72) | < 0.001 | 2.14 (1.69–2.72) | < 0.001 | 2.03 (1.60–2.59) | < 0.001 |
| Female | |||||||
| Normotension | 269 (9.0) | 1 | 1 | 1 | |||
| Hypertension | 566 (20.3) | 2.23 (1.89–2.63) | < 0.001 | 1.63 (1.36–1.95) | < 0.001 | 1.56 (1.30–1.88) | < 0.001 |
Abbreviations. CI: confidence interval; OR: odds ratio; QTc: QT interval corrected for heart rate with Bazett's formula.
Note. Model 1: adjusted for age, gender, and race; Model 2: additional adjustments for BMI, FBG, TC, TG, LDL-C, HDL-C, SUA, current smoking, drinking status, serum calcium, potassium and magnesium, heart rate, history of heart disease, and any medication used; Model 3: additional adjustments for LVH.